Open AccessTreatment Quality and Outcomes of African American Versus White Breast Cancer Patients: Retrospective Analysis of Southwest Oncology Studies S8814/S8897
Author(s) -
Dawn L. Hershman,
Joseph M. Unger,
William E. Barlow,
Laura F. Hutchins,
Silvana Martino,
C. Kent Osborne,
Robert B. Livingston,
Kathy S. Albain
Publication year - 2009
Publication title -
journal of clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 10.482
H-Index - 548
eISSN - 1527-7755
pISSN - 0732-183X
DOI - 10.1200/jco.2008.19.1163
Subject(s) - medicine , breast cancer , discontinuation , hazard ratio , oncology , cancer , chemotherapy , retrospective cohort study , gynecology , gastroenterology , confidence interval
Women of African ancestry (AA) have lower WBC counts and are more likely to have treatment delays and discontinue adjuvant breast cancer therapy early compared with white women. We assessed the association between race and treatment discontinuation/delay, WBC counts, and survival in women enrolled onto breast cancer clinical trials.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom